Showing results (1741-1750 of 2,013) with videos related to
Sort By:
Pageof 202
Carcinogenesis|October 15, 2009
Vascular endothelial growth factor-C (VEGF-C) promotes angiogenesis by induction of COX-2 in leukemic cells via the VEGF-R3/JNK/AP-1 pathwayMing-Hsien Chien, Chia-Chi Ku, Gunnar Johansson, et al.Zhonghua Yi Xue Za Zhi|July 21, 2005
[Identification of signature amino acids in the env V3-V4 and flanking regions of human immunodeficiency virus type 1 predominant strains in China]Hao Liang, Hui Xing, Jonathan Z Li, et al.Journal of Immunology (Baltimore, Md. : 1950)|September 5, 2008
TGF-beta utilizes SMAD3 to inhibit CD16-mediated IFN-gamma production and antibody-dependent cellular cytotoxicity in human NK cellsRossana Trotta, Jessica Dal Col, Jianhua Yu, et al.Pain Physician|May 14, 2021
Can Additional Facet Joint Block Improve the Clinical Outcome of Kyphoplasty for Acute Osteoporotic Vertebral Compression Fractures?Qing-Da Li, Jun-Song Yang, Han-Lin Gong, et al.Zhonghua Yi Xue Za Zhi|December 17, 2008
[Impacted cancellous autograft for reconstructing bone defects of tibial plateau in total knee arthroplasty]Xu Cai, Yan Wang, Ji-fang Wang, et al.Zhonghua Yi Xue Za Zhi|August 6, 2003
[Clinical analysis of 190 cases of outbreak with atypical pneumonia in Guangzhou in spring, 2003]Zi-wen Zhao, Fu-chun Zhang, Min Xu, et al.British Journal of Pharmacology|January 27, 2011
Honokiol ameliorates renal fibrosis by inhibiting extracellular matrix and pro-inflammatory factors in vivo and in vitroChih-Kang Chiang, Meei-Ling Sheu, Yi-Wei Lin, et al.Biochemical Pharmacology|January 18, 2006
Epidermal growth factor receptor inhibitor (PD168393) potentiates cytotoxic effects of paclitaxel against androgen-independent prostate cancer cellsYeong-Shiau Pu, Min-Wei Hsieh, Chuang-Wei Wang, et al.The Journal of Cell Biology|January 16, 2008
Longevity mutation in SCH9 prevents recombination errors and premature genomic instability in a Werner/Bloom model systemFederica Madia, Cristina Gattazzo, Min Wei, et al.Journal of Molecular Medicine (Berlin, Germany)|March 17, 2012
Oncogenic CUL4A determines the response to thalidomide treatment in prostate cancerShancheng Ren, Chuanliang Xu, Zilian Cui, et al.Pageof 202